)
STAAR Surgical Company (STAA) investor relations material
STAAR Surgical Company Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
2025 was a year of transition with leadership changes, cost reductions, and operational restructuring following the terminated Alcon merger.
Q4 2025 net sales rose 18.1% year-over-year to $57.8 million, driven by a rebound in China, while net sales excluding China fell 2.1%.
Fiscal year 2025 net sales declined 23.7% year-over-year to $239.4 million, mainly due to inventory reductions in China; excluding China, sales grew 6.6%.
The company is focused on growth, profitability, and innovation for 2026, with optimism for improved performance in China and globally.
Expanded product indications and new launches, such as EVO+ in China and the LIOLI injector in EMEA, are expected to drive future growth.
Financial highlights
Q4 2025 net sales were $57.8M, up from $49M in Q4 2024, driven by a rebound in China and growth in the Americas and APAC ex-China.
China net sales in Q4 2025 were $17.5M, up from $7.8M in Q4 2024, despite inventory returns and distributor uncertainty.
Gross margin for Q4 2025 was 75.7%, up from 64.7% in the prior year quarter, and remained stable at 76.2% for the year.
Adjusted EBITDA was breakeven in Q4 2025 and a loss of $6.6M for the year, compared to positive $23.2M in 2024.
Ended Q4 2025 with $187.5M in cash equivalents and no debt.
Outlook and guidance
No formal financial guidance for 2026, but management targets significant sales growth and a return to profitability.
Expect modest growth in China net sales in 2026, driven by higher ASPs and market share gains.
Gross margin expected to be slightly lower in 2026 due to higher Swiss manufacturing costs and increased inventory reserves, with improvements anticipated in 2027.
Cash generation expected to resume in the second half of 2026, ending the year with a higher cash balance.
Optimism for business performance in 2026, with focus on sustainable profitability and growth.
Next STAAR Surgical Company earnings date
Next STAAR Surgical Company earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)